Comparison of norepinephrine and dobutamine in patients in cardiogenic shock - NORDIST

AZIENDA USL TOSCANA SUD EST Sezione di Arezzo0 个研究点目标入组 46 人开始时间: 2021年6月1日最近更新: 2022年3月2日

适应症

试验速览

暂无简介。

•Cardiogenic shock with: systolic systemic blood pressure (PAS) <90 mmHg or mean arterial pressure (MAP) <60 mmHg for at least 30 consecutive minutes and the need for pharmacological support (inotropic and / or vasopressors) to maintain a PAS> 90 mmHg or MAP > 60 mmHg;
•Over the age of 18;
•Enrollment within 3 hours of the acute event,
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 46
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 46

•Pregnancy in progress;
•Presence of at least moderate aortic and / or mitral valve disease;
•Septic or hypovolemic shock
•Mechanical complications of acute myocardial infarction (rupture of the free wall of the heart, interventricular defect, papillary rupture.
•Arrhythmic storm, persistent or chronic tachycardic atrial fibrillation.
•Patient enrolled in another study
•Infusion of inotropes / vasoconstrictors already in place at the time of randomization

发起方

AZIENDA USL TOSCANA SUD EST Sezione di Arezzo